These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Diagnostic value of [ 68 Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study. Manafi-Farid R; Mahini M; Mirshahvalad SA; Fallahi B; Fard-Esfahani A; Emami-Ardekani A; Eftekhari M; Mousavi SA; Beiki D Nucl Med Commun; 2024 Mar; 45(3):221-228. PubMed ID: 38214076 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic efficacy of C-X-C motif chemokine receptor 4-directed PET/CT in newly diagnosed head and neck squamous cell carcinoma - a head-to-head comparison with [ Zhi Y; Werner RA; Schirbel A; Higuchi T; Buck AK; Kosmala A; Bley TA; Hagen R; Hackenberg S; Rosenwald A; Scherzad A; Gerhard-Hartmann E; Serfling SE Am J Nucl Med Mol Imaging; 2023; 13(5):208-216. PubMed ID: 38023816 [TBL] [Abstract][Full Text] [Related]
13. Different extramedullary disease shown in chemokine receptor 4 targeted PET/CT with [ 68 Ga]Ga-pentixafor in patients with Waldenström macroglobulinemia and smoldering disease. Pan Q; Cao X; Li J; Li F; Luo Y Nucl Med Commun; 2024 Aug; 45(8):727-735. PubMed ID: 38745523 [TBL] [Abstract][Full Text] [Related]
14. Assessment of Central Nervous System Lymphoma Based on CXCR4 Expression In Vivo Using 68Ga-Pentixafor PET/MRI. Starzer AM; Berghoff AS; Traub-Weidinger T; Haug AR; Widhalm G; Hacker M; Rausch I; Preusser M; Mayerhoefer ME Clin Nucl Med; 2021 Jan; 46(1):16-20. PubMed ID: 33208624 [TBL] [Abstract][Full Text] [Related]
15. Automated Whole-Body Bone Lesion Detection for Multiple Myeloma on Xu L; Tetteh G; Lipkova J; Zhao Y; Li H; Christ P; Piraud M; Buck A; Shi K; Menze BH Contrast Media Mol Imaging; 2018; 2018():2391925. PubMed ID: 29531504 [TBL] [Abstract][Full Text] [Related]
16. 68 Ga-Pentixafor PET/CT for In Vivo Imaging of CXCR4 Receptors in Glioma Demonstrating a Potential for Response Assessment to Radiochemotherapy: Preliminary Results. Waheed A; Singh B; Watts A; Kaur H; Singh H; Dhingra K; Ahuja C; Madan R; Singh A; Radotra BD Clin Nucl Med; 2024 Apr; 49(4):e141-e148. PubMed ID: 38350065 [TBL] [Abstract][Full Text] [Related]
17. 68 Ga-Pentixafor PET/CT for in-vivo mapping of CXCR4 receptors as potential radiotheranostic targets in soft tissue and bone sarcoma: preliminary results. Jena SR; Watts A; Aggarwal P; Bachhal V; Kaur H; Dhingra K; Singh H; Bal A; Singh B Nucl Med Commun; 2024 Mar; 45(3):229-235. PubMed ID: 38165171 [TBL] [Abstract][Full Text] [Related]
18. Advances in PET Imaging of the CXCR4 Receptor: [ Lindenberg L; Ahlman M; Lin F; Mena E; Choyke P Semin Nucl Med; 2024 Jan; 54(1):163-170. PubMed ID: 37923671 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4. Yang T; Shi D; Lin Q; Shen H; Tan H; Liu Y; Shi H; Cheng D Mol Pharm; 2024 May; 21(5):2415-2424. PubMed ID: 38606663 [TBL] [Abstract][Full Text] [Related]
20. CXCR4-Targeted 68 Ga-Pentixafor PET/CT Imaging in Inflammatory Bowel Disease. Chen Y; Yuan H; Tan X; Shang Y; Sun X; Wang P; Jiang L Clin Nucl Med; 2024 Sep; 49(9):817-821. PubMed ID: 39086048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]